Long-Term Mortality and Morbidity Related to Congestive Heart Failure with Reduced Ejection Fraction (CHFrEF) in Palestinian Patients Maintained on Submaximal Sacubitril/Valsartan Doses: A Pilot Study.

Raed Aqel Tareq Z Alzughayyar Sadi A Abukhalaf Rami A Misk Jihad Samer Zalloum

Published in: Journal of the renin-angiotensin-aldosterone system : JRAAS (2021)

A significant long-term reduction in the mortality and morbidity rates was observed in Palestinian patients with HFrEF maintained on submaximal doses of sacubitril/valsartan.

Keyphrases

ejection fraction
heart failure
end stage renal disease
cardiovascular events
newly diagnosed
chronic kidney disease
left ventricular
type diabetes
cardiac resynchronization therapy
patient reported